Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Jisuikang, a Chinese herbal formula, increases neurotrophic factor expression and promotes the recovery of neurological function after spinal cord injury

Jisuikang, a Chinese herbal formula, increases neurotrophic factor expression and promotes the recovery of neurological function after spinal cord injury

Neural Regeneration Research, 2017 · DOI: 10.4103/1673-5374.215264 · Published: September 1, 2017

Spinal Cord InjuryAlternative MedicineNeurology

Simple Explanation

This study investigates the effects of Jisuikang (JSK), a Chinese herbal formula, on spinal cord injury (SCI) recovery in rats. The researchers hypothesized that JSK could help prevent secondary spinal cord injury by influencing the expression of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). Prednisolone (PED) was used as a positive control. A rat model of acute SCI was established, and the rats were treated with different doses of JSK or prednisolone. The motor function recovery was assessed using behavioral tests, and the spinal cord tissue was examined using various techniques to evaluate the expression of NGF and BDNF. The study found that JSK, particularly at a moderate dose, can upregulate BDNF and NGF expression for a prolonged period after spinal cord injury, similar to prednisolone. This suggests that JSK can promote the repair of acute spinal cord injury.

Study Duration
14 days
Participants
180 adult female Sprague-Dawley rats
Evidence Level
Not specified

Key Findings

  • 1
    Moderate-dose Jisuikang group showed the best recovery at 14 days post-injury, as assessed by Basso, Beattie, and Bresnahan locomotor scale scores and the oblique board test.
  • 2
    Hematoxylin-eosin staining and transmission electron microscopy showed that the survival rate of neurons in treatment groups increased after 3–7 days of administration, with more distinct neuron and glial cell structure, particularly in prednisolone and moderate-dose Jisuikang groups.
  • 3
    Jisuikang can upregulate BDNF and NGF expression for a prolonged period after spinal cord injury and promote repair of acute spinal cord injury, with its effect being similar to prednisolone.

Research Summary

This study investigates the potential of Jisuikang (JSK), a Chinese herbal formula, to promote neurological function recovery after spinal cord injury (SCI) by upregulating neurotrophic factor expression. A rat model of acute SCI was used to assess the effects of JSK and prednisolone (PED) on motor function and nerve regeneration. The results showed that moderate-dose JSK improved motor function recovery and increased neuron survival rates in the treatment groups. Further analysis revealed that JSK upregulates the expression of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in injured segments. The study concludes that JSK can promote the repair of acute spinal cord injury by upregulating BDNF and NGF expression, with its effect being similar to prednisolone. These findings suggest that JSK may be a potential therapeutic agent for SCI.

Practical Implications

Potential Therapeutic Agent

Jisuikang could serve as a potential therapeutic agent for spinal cord injury due to its ability to upregulate BDNF and NGF expression.

Traditional Chinese Medicine

This study provides scientific evidence supporting the use of traditional Chinese medicine in treating neurological disorders, specifically spinal cord injury.

Drug Development

The findings may lead to the development of new drugs or therapies based on the mechanisms of action of Jisuikang in promoting nerve regeneration.

Study Limitations

  • 1
    The timeline was short and it is difficult to fully evaluate any curative effect.
  • 2
    Did not use methylprednisolone, which has a clinical curative effect, as a positive control.
  • 3
    The specific molecular pathway mechanism of JSK that promotes BDNF and NGF expression is not yet clear

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury